echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > JAMA Neurology: SARS-CoV-2 infection may cause immune myopathy

    JAMA Neurology: SARS-CoV-2 infection may cause immune myopathy

    • Last Update: 2021-06-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Clinical studies have reported that COVID-19 patients have symptoms such as myalgia, elevated creatine kinase levels, and persistent muscle weakness
    .


    Does SARS-CoV-2 infection have covid -19 related myopathy? Is this disease a post-virus phenomenon? There is no research report at present


    COVID-19 infection

    Recently, JAMA Neurology published a report on histopathological, virological, immunological and ultrastructural research results of skeletal muscle samples from individuals who died from severe COVID-19 , and compared them with skeletal muscle samples from non-COVID-19 critically ill patients.
    Compare
    .

    JAMA Immunization

    This case-control autopsy study included patients with COVID-19 or other major diseases who died between March 2020 and February 2021 and underwent an autopsy
    .


    Individuals who had informed consent to anatomy were randomly selected and the anatomy interval was no more than 6 days


    43 cases of COVID-19 patients (median age [quartile range], 72[16] years; 31 males (72%) and 11 non-COVID-19 patients (median age [quartile range] Range], 71[5] years old; including 7 males (64%)
    .

    Skeletal muscle samples from patients who died from COVID-19 showed higher overall pathology scores (mean [SD], 3.
    4 [1.
    8] vs 1.
    5 [1.
    0]; 95% confidence interval, 0-3; P<0.
    001) and higher Inflammation score (mean [SD], 3.
    5 [2.
    1] vs 1.
    0 [0.
    6]; 95% confidence interval, 0-4; P <0.
    001)
    .


    Among 42 specimens of COVID-19 patients, 23 cases (55%) were related to the expression of MHC class I antigens on the muscle fiber membranes, and 7 cases (17%) of 42 cases of COVID-19 patients had up-regulated expressions of MHC class II antigens, but in the control group None were found


    Skeletal muscle samples from patients who died from COVID-19 showed higher overall pathology scores Skeletal muscle samples from patients who died from COVID-19 showed higher overall pathology scores and higher inflammation scores and higher inflammation scores

    Compared with COVID-19 patients, skeletal muscle inflammation changes in non-COVID-19 critically ill patients

    Compared with COVID-19 patients, skeletal muscle inflammation changes in non-COVID-19 critically ill patients

    Immunohistochemistry showed natural killer cells, no SARS-CoV-2 spike protein was detected

    Immunohistochemistry showed natural killer cells, no SARS-CoV-2 spike protein was detected

    The inflammatory characteristics of skeletal muscle are more than that of myocardium, and the inflammation is most obvious in patients with chronic COVID-19
    .


    In some muscle samples, SARS-CoV-2 RNA was detected by PCR reaction, but immunohistochemistry and electron microscopy did not find evidence of direct viral infection of muscle fibers


    Skeletal muscle has more inflammatory features than myocardium, and inflammation is most obvious in patients with chronic COVID-19


    Most severely ill patients with COVID-19 show symptoms of myositis ranging from mild to severe


    Aschman T, Schneider J, Greuel S, et al.


    Aschman T, Schneider J, Greuel S, et al.
    Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.
      JAMA Neurol.
     Published online June 11, 2021.
    doi:10.
    1001/jamaneurol.
    2021.
    2004 Aschman T , Schneider J, Greuel S, et al.
    Association Between SARS-CoV-2 Infection and Immune-Mediated Myopathy in Patients Who Have Died.
      JAMA Neurol.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.